Taysha Gene Therapies, Inc. Annual Operating Lease, Payments in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Taysha Gene Therapies, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2023.
  • Taysha Gene Therapies, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $2.74M, a 296% increase year-over-year.
  • Taysha Gene Therapies, Inc. annual Operating Lease, Payments for 2023 was $2.82M, a 13.6% increase from 2022.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.82M +$338K +13.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $2.49M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.